ImmunityBio (IBRX) Interest Coverage Ratio Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -13.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.67% |
| Dec 31, 2025 | -63.39% |
| Sep 30, 2025 | -33.23% |
| Jun 30, 2025 | -38.14% |
| Mar 31, 2025 | -30.20% |
| Dec 31, 2024 | 98.75% |
| Sep 30, 2024 | -19.61% |
| Jun 30, 2024 | -26.25% |
| Mar 31, 2024 | 13.65% |
| Dec 31, 2023 | -4,790.11% |
| Sep 30, 2023 | 57.76% |
| Jun 30, 2023 | 67.83% |
| Mar 31, 2023 | 66.89% |
| Dec 31, 2022 | 125.78% |
| Sep 30, 2022 | 75.17% |
| Jun 30, 2022 | 65.81% |
| Mar 31, 2022 | 58.49% |
| Dec 31, 2021 | -62.12% |
| Sep 30, 2021 | 26.29% |
| Jun 30, 2021 | -0.14% |
| Mar 31, 2021 | -40.15% |
| Mar 31, 2018 | -24.54% |
| Dec 31, 2017 | -9.91% |
| Sep 30, 2017 | 94.50% |